Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPrecision oncology is becoming mainstream in clinical practice and research, driving the development of high-technology diagnostics and innovative treatments. Targetable molecular alterations enable treatment individualism and lead to increase of treatment efficacy.
Join us as we explore the evolving landscape of biomarkers and their impact on oncology markets across different tumor types and geographies. In addition, we will uncover the fundamentals of immunotherapies in oncology, as we welcome Lien Lybaert, CEO of Persomed, who will join us to share her immunotherapy expertise and unveil the groundbreaking development of a cancer vaccine for colorectal cancer.
Vladimir works as Associate Director at IQVIA and is responsible for product & strategy for our Global Oncology group.
Prior to moving to his current position, Vladimir was Country Commercial Lead with IQVIA, responsible for all commercial activities in Croatia. Before joining IQVIA, he gained oncology experience with the pharmaceutical industry and held various positions within sales, marketing and business development. Overall, Vladimir has more than 22 years of pharmaceutical industry experience.
Vladimir holds a Master of Pharmacy degree from Zagreb University, as well as a Master’s degree in Health Economics and Pharmacoeconomics from Pompeu Fabra University in Barcelona.
Kriti Jindal is a Client Service manager in the Global Oncology team at IQVIA London. She has been a part of this team for 4 years. Kriti is a specialist in IQVIA’s syndicated oncology patient data. In her current role, she is responsible for understanding project requirements, developing fit for purpose solutions, and executing & delivering end to end projects, using IQVIA’s syndicated offering ‘Oncology Dynamics’. Kriti has participated in many poster presentations at international congresses, such as ESMO, ASCO, and ASH.
Prior to this role, she has worked for 3 years as a custom market research consultant at IQVIA. In this position, she gained experience in different therapy areas through projects spanning market assessment, market access, digital health, and social media listening. Kriti also has knowledge of consumer goods market and wet-lab R&D from her previous work experiences.
Lien studied pharmaceutical sciences where she focused on targeted cancer therapy in her master thesis. After her studies, she did an IWT-funded PhD in the lab of Biopharmaceutical Technology of Prof. Bruno De Geest at Ghent University where she focused on the design of immune-modulating generic polymeric strategies for personalised cell-based cancer vaccination. During her PhD she went abroad as FWO-funded visiting researcher in the lab of Prof. Aaron Esser-Kahn at the University of California, Irvine where she researched TLR-ligand adjuvant functionalisation of cancer vaccines.
Lien is scientific and clinical alliance manager at myNEO where her expertise in the immune-oncology field as well as her in-depth knowledge of tumour immuno-biology and therapeutic strategies, make her the link between the bioinformatics team, the collaborating laboratories, hospitals, and universities as well as the partners of myNEO.Lien is also acting interim CEO of Persomed where she manages and coordinates the investment round and the preparation for the clinical phase I in metastatic colorectal cancer patients.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.
